Editorial

Tech Edge hosted a fireside chat on Dec. 10 at Nasdaq MarketSite with Jeff Winter,...

By Karen Roman Agendia, Inc. said it will present data to assess treatment decisions on patients...

By Karen Roman Institutional target allocations to real estate are set to decline in 2025...

By Karen Roman Agendia, Inc. said it will present MammaPrint’s ability to predict chemotherapy benefit...

By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer...

By Karen Roman Biopharma company Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it finished patient enrollment...

By Karen Roman ReAlta Life Sciences said it is presenting new data at the American...

By Daniella Nanox (Nasdaq: NNOX), received FDA clearance to produce tomographic images for broader diagnostic...

By Karen Roman OmniScience and INmune Bio, Inc. (Nasdaq: INMB) said they’re using genAI in...

  By Karen Roman Agendia, Inc. said its gene expression profiling test MammaPrint can predict...